(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

CHO PHARMA

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

CHO PHARMA

ST13

US500000086714741

Classe

5

Pedido

86714741

Registro

5313817

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

49

Atualização mais recente

01/12/2023

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5

Data de depósito

04/08/2015

Data de registro

17/10/2017

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

01/12/2023

Última transação

01/12/2023

Escritório responsável

United States Patent and Trademark Office

Código da situação

701

Cadastro oficial

Supplemental Register

Fundamento do pedido

Foreign priority

Código do desenho

4

Tipo de titular

03

Localização do titular

Taipei City, TW

Examinador

HERRERA-MARCUS, ROSELLE

Unidade examinadora

N60

Localização atual

TMO LAW OFFICE 124

Titulares e representantes

Titulares

CHO PHARMA INC.
CHO PHARMA INC.

Representantes

Michael T. Smith BIRCH, STEWART, KOLASCH & BIRCH, LLP

Classificação técnica

Classes Nice

Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Medicines for human purposesanti-tumorsanti-cancersanti-infectionsimmune regulation and endocrine regulation; Veterinary preparations for anti-tumorsanti-cancersanti-infectionsimmune regulation and endocrine regulation; Vaccines; Pharmaceutical preparations for human use for the prevention of tumorscancersimmune diseases/disorders infections and metabolic diseases; Biological preparations for medical purposes for the treatment of tumorscancersimmune diseases/disordersinfections and metabolic diseases; Capsules for medicines for the treatment of tumorscancersimmune diseases/disorders infections and metabolic diseases; Veterinary preparations for the treatment of tumorscancersimmune diseases/disordersinfections and metabolic diseases; Nutritional supplements; Dietary supplements for human health; Nutritional supplements for medical purposes for human boosting energypromoting human health; Chemical preparations for pharmaceutical purposesfor anti-tumorsanti-cancersanti-infectionsimmune regulationendocrine regulation and health improvement; Chemical preparations for medical purposesfor anti-tumorsanti-cancersanti-infectionsimmune regulation and endocrine regulation; Chemical preparations for veterinary purposes namelyfor anti-tumorsanti-cancersanti-infectionsimmune regulation and endocrine regulation; Vitamin nutritional supplements; Plant extract nutritional supplements; Diagnostic preparations for medical purposes; Surgical implants comprising of living tissues; Surgical adhesive tapes; Surgical dressings; Preparations for the treatment of burns

Publicações

Histórico de despachos e eventos da marca no USPTO.

49 publicações encontradas

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

01/12/2023

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

01/12/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/12/2023

ES8R

TEAS SECTION 8 RECEIVED

29/08/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

17/10/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/11/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/11/2020

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

05/11/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/11/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/11/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

05/11/2020

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

17/10/2017

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

14/09/2017

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

07/09/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/09/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/09/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

31/08/2017

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

29/08/2017

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

29/08/2017

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/03/2017

GNRT

NON-FINAL ACTION E-MAILED

04/03/2017

CNRT

NON-FINAL ACTION WRITTEN

04/03/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/02/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/02/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/02/2017

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

13/09/2016

GNRT

NON-FINAL ACTION E-MAILED

13/09/2016

CNRT

NON-FINAL ACTION WRITTEN

13/09/2016

ZZBX

ALLOWANCE WITHDRAWN-INADVERTENTLY ISSUED ACTION

13/09/2016

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

29/08/2016

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

19/07/2016

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

06/07/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

29/06/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/06/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/06/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/06/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/06/2016

GNRT

NON-FINAL ACTION E-MAILED

09/06/2016

CNRT

NON-FINAL ACTION WRITTEN

09/06/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/06/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/06/2016

ALIE

ASSIGNED TO LIE

03/06/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

23/05/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

23/11/2015

GNRT

NON-FINAL ACTION E-MAILED

23/11/2015

CNRT

NON-FINAL ACTION WRITTEN

23/11/2015

DOCK

ASSIGNED TO EXAMINER

16/11/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/08/2015

NWAP

NEW APPLICATION ENTERED

07/08/2015

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace CHO PHARMA ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.